nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A5—Teniposide—lymphatic system cancer	0.091	0.173	CbGbCtD
Quetiapine—CYP2C19—Teniposide—lymphatic system cancer	0.0734	0.14	CbGbCtD
Quetiapine—CYP3A7—Vincristine—lymphatic system cancer	0.0584	0.111	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0584	0.111	CbGbCtD
Quetiapine—CYP3A5—Vincristine—lymphatic system cancer	0.0438	0.0833	CbGbCtD
Quetiapine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0414	0.0788	CbGbCtD
Quetiapine—CYP3A4—Cytarabine—lymphatic system cancer	0.036	0.0685	CbGbCtD
Quetiapine—CYP3A4—Teniposide—lymphatic system cancer	0.0355	0.0675	CbGbCtD
Quetiapine—ABCB1—Vincristine—lymphatic system cancer	0.0285	0.0542	CbGbCtD
Quetiapine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0248	0.0472	CbGbCtD
Quetiapine—ABCB1—Methotrexate—lymphatic system cancer	0.0173	0.0328	CbGbCtD
Quetiapine—CYP3A4—Vincristine—lymphatic system cancer	0.0171	0.0325	CbGbCtD
Quetiapine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000565	0.00119	CcSEcCtD
Quetiapine—Tremor—Carmustine—lymphatic system cancer	0.000563	0.00119	CcSEcCtD
Quetiapine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000562	0.00118	CcSEcCtD
Quetiapine—Infection—Bleomycin—lymphatic system cancer	0.000558	0.00118	CcSEcCtD
Quetiapine—Anaemia—Carmustine—lymphatic system cancer	0.000555	0.00117	CcSEcCtD
Quetiapine—Back pain—Vincristine—lymphatic system cancer	0.000555	0.00117	CcSEcCtD
Quetiapine—Vomiting—Teniposide—lymphatic system cancer	0.000554	0.00117	CcSEcCtD
Quetiapine—Agitation—Carmustine—lymphatic system cancer	0.000552	0.00116	CcSEcCtD
Quetiapine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00055	0.00116	CcSEcCtD
Quetiapine—Asthenia—Fludarabine—lymphatic system cancer	0.00055	0.00116	CcSEcCtD
Quetiapine—Rash—Teniposide—lymphatic system cancer	0.00055	0.00116	CcSEcCtD
Quetiapine—Dermatitis—Teniposide—lymphatic system cancer	0.000549	0.00116	CcSEcCtD
Quetiapine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000547	0.00115	CcSEcCtD
Quetiapine—Headache—Teniposide—lymphatic system cancer	0.000546	0.00115	CcSEcCtD
Quetiapine—Pruritus—Fludarabine—lymphatic system cancer	0.000542	0.00114	CcSEcCtD
Quetiapine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000542	0.00114	CcSEcCtD
Quetiapine—Back pain—Mitoxantrone—lymphatic system cancer	0.00054	0.00114	CcSEcCtD
Quetiapine—Leukopenia—Carmustine—lymphatic system cancer	0.000538	0.00113	CcSEcCtD
Quetiapine—Anorexia—Bleomycin—lymphatic system cancer	0.000536	0.00113	CcSEcCtD
Quetiapine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000534	0.00113	CcSEcCtD
Quetiapine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000531	0.00112	CcSEcCtD
Quetiapine—Anaemia—Vincristine—lymphatic system cancer	0.00053	0.00112	CcSEcCtD
Quetiapine—Agitation—Vincristine—lymphatic system cancer	0.000527	0.00111	CcSEcCtD
Quetiapine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000527	0.00111	CcSEcCtD
Quetiapine—Polyuria—Methotrexate—lymphatic system cancer	0.000526	0.00111	CcSEcCtD
Quetiapine—Hypotension—Bleomycin—lymphatic system cancer	0.000525	0.00111	CcSEcCtD
Quetiapine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000524	0.00111	CcSEcCtD
Quetiapine—Convulsion—Carmustine—lymphatic system cancer	0.000521	0.0011	CcSEcCtD
Quetiapine—Hypertension—Carmustine—lymphatic system cancer	0.000519	0.00109	CcSEcCtD
Quetiapine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000518	0.00109	CcSEcCtD
Quetiapine—Nausea—Teniposide—lymphatic system cancer	0.000518	0.00109	CcSEcCtD
Quetiapine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000516	0.00109	CcSEcCtD
Quetiapine—Vertigo—Vincristine—lymphatic system cancer	0.000515	0.00109	CcSEcCtD
Quetiapine—Leukopenia—Vincristine—lymphatic system cancer	0.000514	0.00108	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000512	0.00108	CcSEcCtD
Quetiapine—Myalgia—Carmustine—lymphatic system cancer	0.000512	0.00108	CcSEcCtD
Quetiapine—Chest pain—Carmustine—lymphatic system cancer	0.000512	0.00108	CcSEcCtD
Quetiapine—Anxiety—Carmustine—lymphatic system cancer	0.00051	0.00107	CcSEcCtD
Quetiapine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000505	0.00106	CcSEcCtD
Quetiapine—Malaise—Mitoxantrone—lymphatic system cancer	0.000504	0.00106	CcSEcCtD
Quetiapine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000501	0.00106	CcSEcCtD
Quetiapine—Renal failure acute—Methotrexate—lymphatic system cancer	0.000501	0.00106	CcSEcCtD
Quetiapine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.0005	0.00105	CcSEcCtD
Quetiapine—Convulsion—Vincristine—lymphatic system cancer	0.000497	0.00105	CcSEcCtD
Quetiapine—Hypertension—Vincristine—lymphatic system cancer	0.000495	0.00104	CcSEcCtD
Quetiapine—Confusional state—Carmustine—lymphatic system cancer	0.000495	0.00104	CcSEcCtD
Quetiapine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00049	0.00103	CcSEcCtD
Quetiapine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000488	0.00103	CcSEcCtD
Quetiapine—Myalgia—Vincristine—lymphatic system cancer	0.000488	0.00103	CcSEcCtD
Quetiapine—Cough—Mitoxantrone—lymphatic system cancer	0.000488	0.00103	CcSEcCtD
Quetiapine—Infection—Carmustine—lymphatic system cancer	0.000487	0.00103	CcSEcCtD
Quetiapine—Vomiting—Fludarabine—lymphatic system cancer	0.000487	0.00103	CcSEcCtD
Quetiapine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000484	0.00102	CcSEcCtD
Quetiapine—Rash—Fludarabine—lymphatic system cancer	0.000483	0.00102	CcSEcCtD
Quetiapine—Dermatitis—Fludarabine—lymphatic system cancer	0.000483	0.00102	CcSEcCtD
Quetiapine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000482	0.00102	CcSEcCtD
Quetiapine—Pain—Bleomycin—lymphatic system cancer	0.000481	0.00101	CcSEcCtD
Quetiapine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00048	0.00101	CcSEcCtD
Quetiapine—Headache—Fludarabine—lymphatic system cancer	0.00048	0.00101	CcSEcCtD
Quetiapine—Tachycardia—Carmustine—lymphatic system cancer	0.000479	0.00101	CcSEcCtD
Quetiapine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000476	0.001	CcSEcCtD
Quetiapine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000476	0.001	CcSEcCtD
Quetiapine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000476	0.001	CcSEcCtD
Quetiapine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000474	0.000999	CcSEcCtD
Quetiapine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000472	0.000994	CcSEcCtD
Quetiapine—Lethargy—Methotrexate—lymphatic system cancer	0.000472	0.000994	CcSEcCtD
Quetiapine—Discomfort—Mitoxantrone—lymphatic system cancer	0.00047	0.000991	CcSEcCtD
Quetiapine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000468	0.000987	CcSEcCtD
Quetiapine—Anorexia—Carmustine—lymphatic system cancer	0.000468	0.000985	CcSEcCtD
Quetiapine—Infection—Vincristine—lymphatic system cancer	0.000465	0.00098	CcSEcCtD
Quetiapine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000463	0.000976	CcSEcCtD
Quetiapine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000462	0.000974	CcSEcCtD
Quetiapine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00046	0.000969	CcSEcCtD
Quetiapine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000459	0.000968	CcSEcCtD
Quetiapine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000458	0.000966	CcSEcCtD
Quetiapine—Hypotension—Carmustine—lymphatic system cancer	0.000458	0.000966	CcSEcCtD
Quetiapine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000456	0.000961	CcSEcCtD
Quetiapine—Nausea—Fludarabine—lymphatic system cancer	0.000455	0.000959	CcSEcCtD
Quetiapine—Infection—Mitoxantrone—lymphatic system cancer	0.000453	0.000955	CcSEcCtD
Quetiapine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000453	0.000954	CcSEcCtD
Quetiapine—Shock—Mitoxantrone—lymphatic system cancer	0.000449	0.000946	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000447	0.000942	CcSEcCtD
Quetiapine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000446	0.000941	CcSEcCtD
Quetiapine—Anorexia—Vincristine—lymphatic system cancer	0.000446	0.000941	CcSEcCtD
Quetiapine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000445	0.000938	CcSEcCtD
Quetiapine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000444	0.000936	CcSEcCtD
Quetiapine—Insomnia—Carmustine—lymphatic system cancer	0.000444	0.000935	CcSEcCtD
Quetiapine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000443	0.000933	CcSEcCtD
Quetiapine—Irritability—Methotrexate—lymphatic system cancer	0.000441	0.00093	CcSEcCtD
Quetiapine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000441	0.000929	CcSEcCtD
Quetiapine—Paraesthesia—Carmustine—lymphatic system cancer	0.00044	0.000928	CcSEcCtD
Quetiapine—Mood swings—Methotrexate—lymphatic system cancer	0.000438	0.000923	CcSEcCtD
Quetiapine—Hypotension—Vincristine—lymphatic system cancer	0.000438	0.000922	CcSEcCtD
Quetiapine—Dyspnoea—Carmustine—lymphatic system cancer	0.000437	0.000922	CcSEcCtD
Quetiapine—Somnolence—Carmustine—lymphatic system cancer	0.000436	0.000919	CcSEcCtD
Quetiapine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000435	0.000916	CcSEcCtD
Quetiapine—Ataxia—Methotrexate—lymphatic system cancer	0.000435	0.000916	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000427	0.000899	CcSEcCtD
Quetiapine—Decreased appetite—Carmustine—lymphatic system cancer	0.000426	0.000899	CcSEcCtD
Quetiapine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000426	0.000898	CcSEcCtD
Quetiapine—Insomnia—Vincristine—lymphatic system cancer	0.000423	0.000893	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000423	0.000892	CcSEcCtD
Quetiapine—Paraesthesia—Vincristine—lymphatic system cancer	0.00042	0.000886	CcSEcCtD
Quetiapine—Pain—Carmustine—lymphatic system cancer	0.000419	0.000884	CcSEcCtD
Quetiapine—Constipation—Carmustine—lymphatic system cancer	0.000419	0.000884	CcSEcCtD
Quetiapine—Breast disorder—Methotrexate—lymphatic system cancer	0.000418	0.00088	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000416	0.000877	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000415	0.000876	CcSEcCtD
Quetiapine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000414	0.000873	CcSEcCtD
Quetiapine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000409	0.000863	CcSEcCtD
Quetiapine—Decreased appetite—Vincristine—lymphatic system cancer	0.000407	0.000858	CcSEcCtD
Quetiapine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000407	0.000857	CcSEcCtD
Quetiapine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000405	0.000854	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000404	0.000852	CcSEcCtD
Quetiapine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000404	0.000852	CcSEcCtD
Quetiapine—Fatigue—Vincristine—lymphatic system cancer	0.000404	0.000851	CcSEcCtD
Quetiapine—Asthenia—Bleomycin—lymphatic system cancer	0.000403	0.00085	CcSEcCtD
Quetiapine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000401	0.000846	CcSEcCtD
Quetiapine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000401	0.000845	CcSEcCtD
Quetiapine—Constipation—Vincristine—lymphatic system cancer	0.0004	0.000844	CcSEcCtD
Quetiapine—Pain—Vincristine—lymphatic system cancer	0.0004	0.000844	CcSEcCtD
Quetiapine—Asthma—Methotrexate—lymphatic system cancer	0.0004	0.000842	CcSEcCtD
Quetiapine—Pruritus—Bleomycin—lymphatic system cancer	0.000398	0.000838	CcSEcCtD
Quetiapine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000396	0.000835	CcSEcCtD
Quetiapine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000396	0.000834	CcSEcCtD
Quetiapine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000393	0.000829	CcSEcCtD
Quetiapine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000392	0.000826	CcSEcCtD
Quetiapine—Pain—Mitoxantrone—lymphatic system cancer	0.00039	0.000822	CcSEcCtD
Quetiapine—Constipation—Mitoxantrone—lymphatic system cancer	0.00039	0.000822	CcSEcCtD
Quetiapine—Abdominal pain—Carmustine—lymphatic system cancer	0.000388	0.000817	CcSEcCtD
Quetiapine—Body temperature increased—Carmustine—lymphatic system cancer	0.000388	0.000817	CcSEcCtD
Quetiapine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000383	0.000807	CcSEcCtD
Quetiapine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000383	0.000807	CcSEcCtD
Quetiapine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000376	0.000792	CcSEcCtD
Quetiapine—Dysuria—Methotrexate—lymphatic system cancer	0.000374	0.000787	CcSEcCtD
Quetiapine—Neutropenia—Methotrexate—lymphatic system cancer	0.000374	0.000787	CcSEcCtD
Quetiapine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000373	0.000786	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000371	0.000783	CcSEcCtD
Quetiapine—Abdominal pain—Vincristine—lymphatic system cancer	0.00037	0.00078	CcSEcCtD
Quetiapine—Body temperature increased—Vincristine—lymphatic system cancer	0.00037	0.00078	CcSEcCtD
Quetiapine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000368	0.000776	CcSEcCtD
Quetiapine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000365	0.000769	CcSEcCtD
Quetiapine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000361	0.000762	CcSEcCtD
Quetiapine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00036	0.00076	CcSEcCtD
Quetiapine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00036	0.00076	CcSEcCtD
Quetiapine—Pneumonia—Methotrexate—lymphatic system cancer	0.000358	0.000755	CcSEcCtD
Quetiapine—Vomiting—Bleomycin—lymphatic system cancer	0.000357	0.000753	CcSEcCtD
Quetiapine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000356	0.000751	CcSEcCtD
Quetiapine—Infestation—Methotrexate—lymphatic system cancer	0.000356	0.000751	CcSEcCtD
Quetiapine—Depression—Methotrexate—lymphatic system cancer	0.000355	0.000749	CcSEcCtD
Quetiapine—Rash—Bleomycin—lymphatic system cancer	0.000354	0.000747	CcSEcCtD
Quetiapine—Dermatitis—Bleomycin—lymphatic system cancer	0.000354	0.000746	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000353	0.000744	CcSEcCtD
Quetiapine—Asthenia—Carmustine—lymphatic system cancer	0.000352	0.000742	CcSEcCtD
Quetiapine—Stomatitis—Methotrexate—lymphatic system cancer	0.000347	0.000732	CcSEcCtD
Quetiapine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000346	0.00073	CcSEcCtD
Quetiapine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000345	0.000727	CcSEcCtD
Quetiapine—Sweating—Methotrexate—lymphatic system cancer	0.000341	0.00072	CcSEcCtD
Quetiapine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000337	0.00071	CcSEcCtD
Quetiapine—Epistaxis—Methotrexate—lymphatic system cancer	0.000336	0.000708	CcSEcCtD
Quetiapine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000336	0.000708	CcSEcCtD
Quetiapine—Asthenia—Vincristine—lymphatic system cancer	0.000336	0.000708	CcSEcCtD
Quetiapine—Diarrhoea—Carmustine—lymphatic system cancer	0.000336	0.000707	CcSEcCtD
Quetiapine—Nausea—Bleomycin—lymphatic system cancer	0.000334	0.000703	CcSEcCtD
Quetiapine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000332	0.000701	CcSEcCtD
Quetiapine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000327	0.00069	CcSEcCtD
Quetiapine—Dizziness—Carmustine—lymphatic system cancer	0.000324	0.000684	CcSEcCtD
Quetiapine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000321	0.000677	CcSEcCtD
Quetiapine—Diarrhoea—Vincristine—lymphatic system cancer	0.00032	0.000675	CcSEcCtD
Quetiapine—Haemorrhage—Methotrexate—lymphatic system cancer	0.00032	0.000674	CcSEcCtD
Quetiapine—Hepatitis—Methotrexate—lymphatic system cancer	0.00032	0.000674	CcSEcCtD
Quetiapine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000317	0.000669	CcSEcCtD
Quetiapine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000316	0.000666	CcSEcCtD
Quetiapine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000313	0.000661	CcSEcCtD
Quetiapine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000312	0.000658	CcSEcCtD
Quetiapine—Vomiting—Carmustine—lymphatic system cancer	0.000312	0.000657	CcSEcCtD
Quetiapine—Dizziness—Vincristine—lymphatic system cancer	0.00031	0.000653	CcSEcCtD
Quetiapine—Rash—Carmustine—lymphatic system cancer	0.000309	0.000652	CcSEcCtD
Quetiapine—Dermatitis—Carmustine—lymphatic system cancer	0.000309	0.000651	CcSEcCtD
Quetiapine—Visual impairment—Methotrexate—lymphatic system cancer	0.000308	0.000649	CcSEcCtD
Quetiapine—Headache—Carmustine—lymphatic system cancer	0.000307	0.000648	CcSEcCtD
Quetiapine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000302	0.000637	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—lymphatic system cancer	0.000299	0.00063	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—lymphatic system cancer	0.000298	0.000628	CcSEcCtD
Quetiapine—Vomiting—Vincristine—lymphatic system cancer	0.000298	0.000627	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000297	0.000625	CcSEcCtD
Quetiapine—Rash—Vincristine—lymphatic system cancer	0.000295	0.000622	CcSEcCtD
Quetiapine—Dermatitis—Vincristine—lymphatic system cancer	0.000295	0.000622	CcSEcCtD
Quetiapine—Headache—Vincristine—lymphatic system cancer	0.000293	0.000618	CcSEcCtD
Quetiapine—Nausea—Carmustine—lymphatic system cancer	0.000291	0.000614	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—lymphatic system cancer	0.00029	0.000611	CcSEcCtD
Quetiapine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00029	0.000611	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000289	0.000609	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000288	0.000607	CcSEcCtD
Quetiapine—Rash—Mitoxantrone—lymphatic system cancer	0.000288	0.000606	CcSEcCtD
Quetiapine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000287	0.000605	CcSEcCtD
Quetiapine—Chills—Methotrexate—lymphatic system cancer	0.000287	0.000605	CcSEcCtD
Quetiapine—Headache—Mitoxantrone—lymphatic system cancer	0.000286	0.000602	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—lymphatic system cancer	0.00028	0.00059	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—lymphatic system cancer	0.000278	0.000587	CcSEcCtD
Quetiapine—Nausea—Vincristine—lymphatic system cancer	0.000278	0.000586	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000273	0.000575	CcSEcCtD
Quetiapine—Nausea—Mitoxantrone—lymphatic system cancer	0.000271	0.000571	CcSEcCtD
Quetiapine—Back pain—Methotrexate—lymphatic system cancer	0.000269	0.000568	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—lymphatic system cancer	0.000262	0.000553	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000258	0.000544	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—lymphatic system cancer	0.000257	0.000542	CcSEcCtD
Quetiapine—Malaise—Methotrexate—lymphatic system cancer	0.000251	0.000529	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—lymphatic system cancer	0.00025	0.000527	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—lymphatic system cancer	0.000249	0.000525	CcSEcCtD
Quetiapine—Cough—Methotrexate—lymphatic system cancer	0.000243	0.000512	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—lymphatic system cancer	0.000241	0.000508	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—lymphatic system cancer	0.000237	0.000499	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—lymphatic system cancer	0.000237	0.000499	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—lymphatic system cancer	0.000237	0.000499	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000235	0.000496	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—lymphatic system cancer	0.000234	0.000494	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—lymphatic system cancer	0.000229	0.000483	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000227	0.000479	CcSEcCtD
Quetiapine—Infection—Methotrexate—lymphatic system cancer	0.000226	0.000476	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000223	0.00047	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000222	0.000469	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—lymphatic system cancer	0.000221	0.000465	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00022	0.000463	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—lymphatic system cancer	0.000217	0.000456	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—lymphatic system cancer	0.000212	0.000447	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000207	0.000436	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—lymphatic system cancer	0.000205	0.000433	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000204	0.00043	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000203	0.000427	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—lymphatic system cancer	0.000202	0.000426	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—lymphatic system cancer	0.0002	0.000421	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000197	0.000416	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000196	0.000413	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—lymphatic system cancer	0.000196	0.000413	CcSEcCtD
Quetiapine—Pain—Methotrexate—lymphatic system cancer	0.000194	0.000409	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000187	0.000395	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000186	0.000392	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00018	0.000379	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00018	0.000379	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000167	0.000353	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—lymphatic system cancer	0.000163	0.000344	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—lymphatic system cancer	0.000161	0.000339	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000155	0.000328	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—lymphatic system cancer	0.00015	0.000317	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—lymphatic system cancer	0.000144	0.000304	CcSEcCtD
Quetiapine—Rash—Methotrexate—lymphatic system cancer	0.000143	0.000302	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—lymphatic system cancer	0.000143	0.000302	CcSEcCtD
Quetiapine—Headache—Methotrexate—lymphatic system cancer	0.000142	0.0003	CcSEcCtD
Quetiapine—Nausea—Methotrexate—lymphatic system cancer	0.000135	0.000284	CcSEcCtD
